These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20627790)

  • 1. Anti-CRP antibodies in systemic lupus erythematosus.
    Meyer O
    Joint Bone Spine; 2010 Oct; 77(5):384-9. PubMed ID: 20627790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C; Wetterö J
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pentraxins - their importance in pathogenesis of systemic lupus erythematosus].
    Jakuszko K; Krajewska M; Weyde W; Grzegorczyk K; Klinger M
    Postepy Hig Med Dosw (Online); 2011 Sep; 65():597-605. PubMed ID: 21918264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in Autoantibodies against C-reactive Protein in Systemic Lupus Erythematosus].
    Li QY; Yu F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):678-684. PubMed ID: 31699200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.
    Bell SA; Faust H; Schmid A; Meurer M
    Clin Exp Immunol; 1998 Sep; 113(3):327-32. PubMed ID: 9737658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
    Padjas A; Undas A; Swadzba J; Musiał J
    Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to C reactive protein.
    Rosenau BJ; Schur PH
    Ann Rheum Dis; 2006 May; 65(5):674-6. PubMed ID: 16176996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet Quality and High-Sensitivity C-Reactive Protein in Patients With Systemic Lupus Erythematosus.
    Pocovi-Gerardino G; Correa-Rodríguez M; Rubio JC; Fernández RR; Ortego-Centeno N; Rueda-Medina B
    Biol Res Nurs; 2019 Jan; 21(1):107-113. PubMed ID: 30282476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].
    Funakubo Asanuma Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):470-80. PubMed ID: 23291482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.
    Su J; Frostegård AG; Hua X; Gustafsson T; Jogestrand T; Hafström I; Frostegård J
    J Rheumatol; 2013 Nov; 40(11):1856-64. PubMed ID: 24037548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus].
    Panafidina TA; Popkova TV; Alekberova ZS; Novikova PS; Mach ES; Aleksandrova EN; Kashnikova LN; Nasonov EL
    Klin Med (Mosk); 2006; 84(10):49-54. PubMed ID: 17201275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.
    Al Gadban MM; Alwan MM; Smith KJ; Hammad SM
    Clin Immunol; 2015 Apr; 157(2):133-44. PubMed ID: 25638414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies.
    Mathsson L; Ahlin E; Sjöwall C; Skogh T; Rönnelid J
    Clin Exp Immunol; 2007 Mar; 147(3):513-20. PubMed ID: 17302901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on cardiovascular disease in lupus.
    Lewandowski LB; Kaplan MJ
    Curr Opin Rheumatol; 2016 Sep; 28(5):468-76. PubMed ID: 27227346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.